Biomarkers 2014

Key Topics

• Considerations for Reimbursement in the Post-approval Process
• Biomarkers In Clinical Development and Emerging Strategies for Patient Enrichment/Stratification as Companion Diagnostics
• Implementation of Translational Biomarkers
• Different "Business Models" in CNS Drug Discovery/Development
• Regulatory Approaches for Biomarker Qualification and the Development of Clinical Diagnostics
• Novel Approaches for Biomarker Qualification and the Development of Clinical Diagnostics
• Technological Approaches for Biomarker Discovery and Development Across Modalities
• Standardization of Analytical Approaches